CollPlant Tests New Treatment for Chronic Wounds

Israel’s CollPlant, which develops and manufactures human collagen-based medical products, has treated the first patient in its VergenixFG clinical trial in Israel. The VergenixFG gel is an advanced gel More...

US patent boosts CollPlant

– – The company was awarded a patent on its method of producing human collagen in plants. –   – Shares in CollPlant Holdings Ltd. (TASE: CLPT) rose strongly on the Tel Aviv Stock More...

Chinese co to commercialize CollPlant products

– The Chinese company will invest $4 million in CollPlant in exchange for an allotment of shares and the commercialization of its products in China. – / By Moshe Golan / CollPlant Holdings Ltd. (TASE: More...